(0 items) Help
Home → Nursing → Pharmacology
By James M. Ritter, DPhil FRCP FBPhS FMedSci, Rod J. Flower, PhD DSc FBPhS FMedSci FRS, Graeme Henderson, BSc PhD FBPhS FSB, Yoon Kong Loke, MB, BS, MRCP, MD, David MacEwan, PhD, FRSB, FBPhS, SFHEA, Emma Robinson, PhD, FBPhS and James Fullerton, MA, MBChB, MRCP, PhD, FHEA.
872 pagesTrim Size 8 7/16 X 10 7/8 inCopyright 2024$80.99, Reference
Rang and Dale’s Pharmacology is internationally acknowledged as the core textbook for students of pharmacology, and has provided accessible, up-to-date information on drugs and their mechanism of action for more than 30 years.
Now in its tenth edition, it has been updated to include important new drugs such as gene therapies, personalised medicines and the new wave of RNA drugs. However it has not lost any of the elements that have contributed to its popularity, such as color coding and illustrations, making it reader-friendly while comprehensively covering the depth of detail required.
This essential book is recommended as the first-choice undergraduate text for science and medical students and junior doctors and will also be useful for students in other professional disciplines such as pharmacy, veterinary medicine and nursing.
By James M. Ritter, DPhil FRCP FBPhS FMedSci, Emeritus Professor of Clinical Pharmacology, King’s College London, and Medical Research Director, Quintiles, London, UK; Rod J. Flower, PhD DSc FBPhS FMedSci FRS, Professor, Biochemical Pharmacology, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London, UK; Graeme Henderson, BSc PhD FBPhS FSB, Professor of Pharmacology, University of Bristol, Bristol, UK; Yoon Kong Loke, MB, BS, MRCP, MD, Senior Lecturer in Clinical Pharmacology, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK; David MacEwan, PhD, FRSB, FBPhS, SFHEA, Professor of Molecular Pharmacology/Toxicology & Head of Department, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom; Emma Robinson, PhD, FBPhS, Professor of Psychopharmacology, University of Bristol, Bristol, UK and James Fullerton, MA, MBChB, MRCP, PhD, FHEA., Associate Professor of Clinical Therapeutics and Honorary Consultant in Acute General Medicine and Clinical Pharmacology, University of Oxford, Oxford, United Kingdom